This study aimed to describe neuromonitoring findings and short-term outcomes after the implementation of a digital health strategy comprising continuous, real-time, tele-based video-aEEG/EEG monitoring in a publicly funded NICU in Brazil. Prospective, observational cohort study conducted between July 2017 and June 2021, analyzing neuromonitoring data of high-risk newborns and correlating it with clinical and imaging outcomes. A total of 116 newborns, with a median gestational age of 37 weeks (interquartile range [IQR]: 322/7–392/7) and a median birth weight of 2,800 g (IQR: 1,472–3,305), were enrolled with more than 8,000 hours of monitoring. The main indication was suspected seizure (n = 49, 42.2%). A total of 43 (37.1%) neonates presented pathological background activity, and sleep–wake cycle (SWC) was absent in 68 (58.6%). Seizures were identified in 36 (31.0%) neonates, predominantly within the first 12 hours of life (n = 14, 38.9%), electrographic-only (n = 29, 80.6%), and repetitive (n = 24, 66.7%). A total of 47 (40.5%) neonates received antiseizure medications, with phenobarbital being the most frequently used (46; 97.9%). Only one patient (2.1%) was discharged receiving antiseizure medication. Cranial ultrasound (cUS) was performed in 94 (81.0%) infants, with abnormal findings in 34 (36.2%) infants. Pathological background activity, absence of SWC, and seizures were significantly associated with severe abnormalities on cUS, and increased risk of death before discharge. The implementation of a digital health strategy incorporating real-time and continuous video-aEEG/EEG monitoring demonstrated potential to improve diagnostic accuracy for electrographic seizures, optimize antiseizure medication stewardship, and inform early neuroprotective interventions. S.S.A., D.M.K.L., T.S.S., P.G.R., J.Q.T., T.M.L.d.O.U.B., C.G.M., A.C.P.B.F., F.B.P.S., M.M., G.F.T.V., and M.J.M.: concept and design; S.S.A., D.M.K.L., P.G.R., J.Q.T., T.M.L.d.O.U.B., C.G.M., A.C.P.B.F., and F.B.P.S.: data collection and analysis; G.F.T.V., and M.J.M.: study supervision. All the authors drafted and revised the manuscript. Received: 20 August 2025 Accepted: 23 November 2025 Article published online: 04 December 2025 © 2025. Thieme. All rights reserved. Thieme Medical Publishers, Inc. 333 Seventh Avenue, 18th Floor, New York, NY 10001, USA